Manjunatha Ankathatti Munegowda, DVM, MS, PhD, mMBA

Manjunatha Ankathatti Munegowda has a diverse work experience spanning various roles in the scientific and veterinary fields. Their most recent position is as the Manager of Scientific Research at Medicenna Therapeutics Corp., where they are currently employed. Prior to this, they worked at Theralase Technologies Inc. from 2016 to 2021 as a Scientist in the field of cancer therapy, specifically focusing on immunotherapy and photodynamic therapy. At Theralase, they played a key role in identifying strategic partners and presenting data.

Before joining Medicenna Therapeutics Corp., Manjunatha worked at Enrich Bioscience in 2021 as a Business Development Manager, with a specific focus on democratizing a minimally invasive single molecular blood test for early cancer diagnosis. Manjunatha also worked with the telepathology arm of Enrich Bioscience, aiming to contribute to the worldwide pathologist network and improve timely diagnosis.

In 2015, Manjunatha was a Postdoctoral Fellow at the Princess Margaret Cancer Centre & University of Toronto, where they researched cancer immunotherapy and worked on evaluating T cell responses under NK cell-based immunotherapy. Prior to that, from 2012 to 2015, they were a Postdoctoral Fellow/Research Fellow at The Hospital for Sick Children & University of Toronto.

Manjunatha's educational background includes a PhD in Tumour Immunology from the University of Saskatchewan, completed between 2006 and 2012. Manjunatha also worked as a Veterinary Doctor at the Department of Animal Husbandry from 2005 to 2006. In addition, they have held research positions at the Indian Institute of Science and the Institute of Animal Health and Veterinary Biologicals from 2004 to 2005. Overall, Manjunatha Ankathatti Munegowda's work experience demonstrates their expertise in scientific research, cancer therapy, immunotherapy, and veterinary medicine.

Manjunatha Ankathatti Munegowda has an extensive education history. Manjunatha obtained a BVSc. & AH (equivalent to DVM) degree from Bangalore Veterinary College from 1997 to 2002, specializing in Veterinary Medicine. Manjunatha then pursued an MVSc (Master in Veterinary Pathology) at the same institution from 2002 to 2004, where their thesis work focused on gross and histopathology.

To further expand their knowledge, Munegowda pursued a PhD in Tumor Immunology from the Department of Pathology and Laboratory Medicine at the University of Saskatchewan from 2007 to 2012. Their research likely involved studying the immune response to tumors.

Additionally, Munegowda acquired a mMBA (Master of Business Administration) degree from the Chicago Institute of Business, specializing in Business Administration and Management, General. The exact time frame of this degree is not provided, but it can be inferred that they obtained it after their PhD since it is mentioned separately.

In terms of certifications, Munegowda completed a Project Management Course at the Chicago Institute of Business in August 2018. Manjunatha also received certifications as a Peer Reviewer in Immunologic Research from Springer Publishing Company and as a Peer Reviewer in the Journal of Clinical Medicine from MDPI, although the specific dates of these certifications are not provided.

Furthermore, Munegowda obtained an mMBA degree from the Chicago Institute of Business in August 2019, which coincides with their certification in the same field.

It should be noted that there is no information provided regarding Munegowda's start and end years for the mMBA degree.